Ceyhan Ceran and Biology - Free people check

(1 - 10 from 11

)

Ceyhan Ceran | Semantic Scholar

www.semanticscholar.org

Oct 04, · Ceyhan Ceran, Murat Cokol, S. Cingoz, I. Tasan, M. Ozturk, T. Yagci; Biology ; TLDR. Novel antibodies against extracellular domain of HER2 may serve as potent anti-cancer bioactive molecules and cell-dependent synergy and antagonism between anti-HER2 antibodies and TNF-α provide evidence for a complex interplay between HER2 and T NF-α ...

Kynurenine pathway in Coronavirus disease (COVID‐19)onlinelibrary.wiley.com › doi › full › jcla

onlinelibrary.wiley.com

29 Jan · Ceyhan Ceran Serdar,. Ceyhan Ceran Serdar. orcid.org Medical Biology and Genetics, Faculty of Medicine, Ankara Medipol ...

Sample size, power and effect size revisited: simplified ...

hrcak.srce.hr

Ceyhan Ceran Serdar1, Murat Cihan2, Doğan Yücel3, Muhittin A Serdar*4 1Medical Biology and Genetics, Faculty of Medicine, Ankara Medipol University, Ankara, Turkey 2Ordu University Training and Research Hospital, Ordu, Turkey 3Department of Medical Biochemistry, Lokman Hekim University School of Medicine, Ankara, Turkey

Novel monoclonal antibodies targeting conformational ERBB lib.net › Diğer

9lib.net

NOVEL MONOCLONAL ANTIBODIES TARGETING. CONFORMATIONAL ERBB2 EPITOPES. 1.4ABSTRACT. Ceyhan Ceran. Ph.D. in Molecular Biology and Genetics Supervisor: Prof.

Sample size, power and effect size revisited: simplified ...

pubmed.ncbi.nlm.nih.gov

Ceyhan Ceran Serdar 1 , Murat Cihan 2 , Doğan Yücel 3 , Muhittin A Serdar 4 Affiliations 1 Medical Biology and Genetics, Faculty of Medicine, Ankara Medipol University, Ankara, Turkey. 2 Ordu University Training and Research Hospital, Ordu, Turkey

Novel anti-HER2 monoclonal antibodies: synergy and ...

www.ncbi.nlm.nih.gov

Oct 04, · Ceyhan Ceran, 1 Murat Cokol, 2 Sultan Cingoz, 3 Ipek Tasan, 1 Mehmet Ozturk, 1 and Tamer Yagci 1, 4 Ceyhan Ceran 1 BilGen Genetics and Biotechnology Research Center, Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey